Found 1 matching record:
Download this epitope record as JSON.
HXB2 Location | Nef(73-81) DNA(9013..9039) |
Nef Epitope Map |
---|---|---|
Author Location | Nef(73-) | |
Epitope |
QVPLRPMTY
|
Epitope Alignment
|
Epitope Name | Nef73 | |
Subtype | A | |
Species (MHC/HLA) | human(B*07) | |
Immunogen | HIV-1 infection, vaccine | |
Patient MHC/HLA | P2: A*68:02, A*74:01, B*35:01, B*53:01; P15: A*23:01, A*31:01, B*35:01, B*41:02; P21: A*02:02, A*23:01, B*14:01, B*35:01 | |
Country | Guinea-Bissau | |
Experimental methods | CD8 T-cell Elispot - IFNγ | |
Keywords | vaccine-induced immune responses, vaccine antigen design, therapeutic vaccine, chronic infection |
Vaccine type | peptide |
---|---|
Vaccine strain | A clade |
Adjuvant | CAF01 |
Roman2013 Victor Raúl Gómez Román, Kristoffer Jarlov Jensen, Sanne Skov Jensen, Christian Leo-Hansen, Sanne Jespersen, David da Silva Té, Candida Medina Rodrigues, Christoph Mikkel Janitzek, Lasse Vinner, Terese Lea Katzenstein, Peter Andersen, Ingrid Kromann, Lars Vibe Andreasen, Ingrid Karlsson, and Anders Fomsgaard. Therapeutic Vaccination Using Cationic Liposome-Adjuvanted HIV Type 1 Peptides Representing HLA-Supertype-Restricted Subdominant T Cell Epitopes: Safety, Immunogenicity, and Feasibility in Guinea-Bissau. AIDS Res Hum Retroviruses, 29(11):1504-1512, Nov 2013. PubMed ID: 23634822. Show all entries for this paper.
This is a legacy search page. It is deprecated, will receive no more updates, and will eventually be removed. Please use the new search pages.